International Probiotics Association to relocate to US; reigning chief resigns

The International Probiotics Association (IPA) is relocating to an unconfirmed US location from Europe in November. The group will replace executive director, Ioannis Misopoulos, who will remain in Switzerland.

“It was decided that IPA will be moving to the US in November and due to personal reasons I have decided to stay in Europe and not follow after being at the helm of the organization the last 7 ½ years,” Misopoulos said in an email to the IPA membership.

“It was a very difficult decision for me but I chose to stay in Switzerland.”

IM.jpg
End of the road: Ioannis Misopoulos won't be following IPA to the US but said he wants to remain in the probiotic sector

Misopoulos thanked the association and its members with whom he had, "truly enjoyed working ... and representing the probiotic industry in government organisations along with helping to set standards.”

The group has not yet said anything about the motivation for the HQ shift.

Misopoulos said he intended to remain in the probiotic sector.

IPA counts more than 50 probiotic suppliers and manufacturers as members including Lallemand, Chr Hansen, Jarrow Formulas, Morinaga, DuPont-Danisco and Yakult.

Related Topics

IngredientsFunctional dairyIngredients

Related news

Probiotics easier to market as drugs than foods: PRI

By Shane STARLING

The EU’s strict nutrition and health claims regulation (NHCR) which has barred all probiotic claims means 'living microorganism'-based products could be easier to bring to market as drugs, a 4-year-old French group has said.

EFSA commits to fresh gut and immune health claim guidance

By Shane STARLING

The EU’s central food science agency will next month open a consultation on immune and gut health that will inform a revised guidance that could come before year’s end and may appease sector anxiety.

IPA calls for fresh global alliance in probiotics

The founder of the International Probiotics Association (IPA) has called on the Global Alliance for Probiotics (GAP) to work with it to develop the science and dossiers that can win health claims in Europe and elsewhere.